stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Return on assets
Pulse Biosciences, Inc's return on assets over the twelve months to 30 September 2026 was −54.0%, up 10.1 percentage points from fiscal 2025 (−64.1%). Over the past ten years it has ranged from −133.3% (fiscal 2021) to −13.8% (fiscal 2015); the current reading is higher than 55% of that period. That is below the Medical Instruments & Supplies industry median of 0.00% and below the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −64.1% | (8.19) |
| FY2024 | −55.9% | 5.68 |
| FY2023 | −61.6% | 26.95 |
| FY2022 | −88.6% | 44.70 |
| FY2021 | −133.3% | (13.44) |
| FY2020 | −119.8% | (36.36) |
| FY2019 | −83.5% | (21.12) |
| FY2018 | −62.3% | 4.82 |
| FY2017 | −67.2% | (20.32) |
| FY2016 | −46.8% | (33.01) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| NVST Envista Holdings Corporation compare | 11.3% |
| MMSI Merit Medical Systems, Inc. compare | 5.76% |
| STVN Stevanato Group S.p.A. compare | 5.50% |
| ATRC AtriCure, Inc. compare | 2.20% |
| ICUI ICU Medical, Inc. compare | 1.50% |
| WRBY Warby Parker Inc. compare | 1.00% |
| MMED MiniMed Group, Inc. compare | −6.27% |
| TFX Teleflex Incorporated compare | −14.6% |
| PLSE Pulse Biosciences, Inc | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement